Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Senseonics Holdings, Inc. develops and manufactures long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its flagship product, Eversense, offers up to one-year sensor life, real-time glucose data via a mobile app, and safety alerts. The company partners with distributors and healthcare providers worldwide, focusing on regulatory approvals, reimbursement, and expanding access through strategic collaborations and innovative product development.
This description was generated via AI from an annual report. Updated about 1 year ago.